BridgeMD
New treatment option for Chronic Low Back Pain (CLBP)
Official title Brain Network Stimulation for Chronic Low Back Pain.
ClinicalTrials.gov ID: NCT06902233
What this study is testing
- What it's testing
- This study looks at the non-invasive brain stimulation technique in people with chronic low back pain to see: How effective non-invasive brain stimulation is at improving pain intensity in people with chronic low back pain? How safe non-invasive brain stimulation is and what side effects there may be?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age between 18 to 75 years on the day of screening
- Pain in the lower back (region between 12th rib and gluteal fold) with or without accompanying leg pain that occurs for at least half the days in the...
- An average pain intensity of ≥4 on the 11-point NPRS (0=No pain to 10=Pain as bad as you can imagine) in the week prior to enrolment
- A disability score of ≥5 on Roland-Morris Disability Questionnaire (RMDQ).
You likely can't join if
- Known or suspected serious spinal pathology (fracture; lumbar canal stenosis, malignant, inflammatory or infective diseases of the spine; cauda...
- Suspected or confirmed pregnancy or less than six months post-partum
- Inflammatory disorders
- Auto-immune conditions
- Recent soft tissue injuries of the back in the last 3 months
- Recent steroid injections to the back in the past 3 months
See the full eligibility criteria
- Age between 18 to 75 years on the day of screening
- Pain in the lower back (region between 12th rib and gluteal fold) with or without accompanying leg pain that occurs for at least half the days in the last six months
- An average pain intensity of ≥4 on the 11-point NPRS (0=No pain to 10=Pain as bad as you can imagine) in the week prior to enrolment
- A disability score of ≥5 on Roland-Morris Disability Questionnaire (RMDQ).
- Known or suspected serious spinal pathology (fracture; lumbar canal stenosis, malignant, inflammatory or infective diseases of the spine; cauda equina syndrome or widespread neurological disorder)
- Suspected or confirmed pregnancy or less than six months post-partum
- Inflammatory disorders
- Auto-immune conditions
- Recent soft tissue injuries of the back in the last 3 months
- Recent steroid injections to the back in the past 3 months
- Recent spinal surgery in the past 12 months or scheduled/waiting for any major surgical procedures during the treatment or follow-up period or underwent rhizotomy or any neurosurgical procedures
- History of neurological conditions, or psychiatric disorders (except depression and anxiety disorders)
- History of cancer, or currently receiving/scheduled for receiving therapy for cancer
- Cognitive impairments (dementia, Alzheimer's disease; indicated by a total score of 24 or below on Mini-Mental State Examination)
- Alcohol or substance abuse
- History of epilepsy or seizures
- Presence of any electronic implants (e.g., pacemaker), metal implant in the body (particularly head and neck), or spinal cord stimulator.
The study team makes the final eligibility decision.
Where it's taking place
- Dunedin, Otago, New Zealand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dunedin, Otago, New Zealand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.